Troponin-T is preferable to CPK-MB in the diagnosis of acute myocardial infraction in all the following situations except
**Core Concept**
Troponin-T and CPK-MB are cardiac biomarkers used to diagnose acute myocardial infarction (AMI). Troponin-T is a more sensitive and specific marker for myocardial damage, while CPK-MB is more specific but less sensitive. The choice between the two markers depends on the clinical scenario.
**Why the Correct Answer is Right**
The correct answer is not explicitly listed, but we can infer that the question is asking for a situation where CPK-MB might be preferable to Troponin-T. This could be in cases where Troponin-T is not elevated due to renal failure, as CPK-MB is primarily excreted by the kidneys. However, this is not the only situation, and we need to examine the options to determine which one is the exception.
**Why Each Wrong Option is Incorrect**
**Option A:**
This option is not provided, so we cannot evaluate it.
**Option B:**
This option is not provided, so we cannot evaluate it.
**Option C:**
This option is not provided, so we cannot evaluate it.
**Option D:**
This option is not provided, so we cannot evaluate it.
However, we can infer that the question is asking for a situation where Troponin-T is not preferable to CPK-MB. In general, Troponin-T is preferred due to its higher sensitivity and specificity. However, there may be situations where CPK-MB is more useful.
**Clinical Pearl / High-Yield Fact**
When using cardiac biomarkers to diagnose AMI, it's essential to consider the patient's renal function, as elevated creatinine levels can falsely lower Troponin-T levels. Additionally, CPK-MB may be elevated in patients with skeletal muscle damage or rhabdomyolysis.
**Correct Answer:**